Drugs / MF59 adjuvanted trivalent subunit influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01162122 | Aug 2010 → Aug 2011 | influenza | Novartis Vaccines | Completed | Mixed |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59 adjuvanted trivalent subunit influenza vaccine | “MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)” NCT01162122 ↗ |
| Known as | aTIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01162122 ↗ |
| Modality | Vaccine | “an MF59(®)-adjuvanted trivalent influenza vaccine (aTIV)” PMID 25045825 ↗ Jul 2014 |
| Route | Intramuscular | “administered IM in the deltoid muscle” NCT01162122 ↗ |